Steph & Co’s AbbVie ABBV Stock Holding History

Steph & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Hold	1,250	–	–	0.08%	81
2026 Q1	$272K	Sell	1,250 -100	-7%	-$22.2K	0.08%	84
2025 Q4	$308K	Hold	1,350	–	–	0.09%	79
2025 Q3	$313K	Hold	1,350	–	–	0.1%	81
2025 Q2	$251K	Hold	1,350	–	–	0.08%	89
2025 Q1	$283K	Hold	1,350	–	–	0.1%	86
2024 Q4	$240K	Hold	1,350	–	–	0.08%	99
2024 Q3	$267K	Sell	1,350 -100	-7%	-$18.7K	0.08%	97
2024 Q2	$249K	Sell	1,450 -1,235	-46%	-$205K	0.08%	96
2024 Q1	$489K	Hold	2,685	–	–	0.17%	65
2023 Q4	$416K	Sell	2,685 -119	-4%	-$17.3K	0.2%	60
2023 Q3	$418K	Buy	2,804 +19	+0.7%	+$2.79K	0.23%	61
2023 Q2	$375K	Hold	2,785	–	–	0.2%	66
2023 Q1	$444K	Hold	2,785	–	–	0.28%	55
2022 Q4	$450K	Hold	2,785	–	–	0.28%	52
2022 Q3	$374K	Hold	2,785	–	–	0.26%	56
2022 Q2	$427K	Hold	2,785	–	–	0.26%	49
2022 Q1	$451K	Hold	2,785	–	–	0.27%	47
2021 Q4	$377K	Hold	2,785	–	–	0.22%	56
2021 Q3	$300K	Hold	2,785	–	–	0.19%	63
2021 Q2	$314K	Hold	2,785	–	–	0.2%	58
2021 Q1	$301K	Hold	2,785	–	–	0.21%	53
2020 Q4	$298K	Hold	2,785	–	–	0.23%	45
2020 Q3	$244K	Sell	2,785 -487	-15%	-$45.8K	0.23%	43
2020 Q2	$321K	Sell	3,272 -6,700	-67%	-$590K	0.32%	34
2020 Q1	$760K	Hold	9,972	–	–	0.86%	25
2019 Q4	$883K	Buy	+9,972	New	+$828K	0.75%	27

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Steph & Co's ABBV Position: Q2 2026 in Review

Steph & Co held its AbbVie (ABBV) position steady in Q2 2026 at 1,250 shares worth $315K. The position accounts for 0.08% of the portfolio, ranked #81.

Steph & Co first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. The position peaked at $883K in Q4 2019. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Steph & Co held 1,250 shares of AbbVie worth $315K as of Q2 2026.
Steph & Co left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.08% of Steph & Co's portfolio in Q2 2026, its #81 holding.
Steph & Co first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
Steph & Co's AbbVie position peaked at $883K in Q4 2019.
4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.